What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
30 Co-sponsors
- Joseph P. Addabbo Jr.
- Fredrick J. Akshar II
- Tony Avella
- Phil Boyle
- Neil D. Breslin
- David Carlucci
- Thomas Croci
- Adriano Espaillat
- Rich Funke
- Patrick M. Gallivan
- Jesse Hamilton
- Brad Hoylman-Sigal
- Liz Krueger
- Andrew J. Lanza
- William J. Larkin Jr.
- George Latimer
- Jack M. Martins
- Velmanette Montgomery
- Thomas F. O'Mara
- Marc Panepinto
- Kevin S. Parker
- Bill Perkins
- Michael H. Ranzenhofer
- Patty Ritchie
- Gustavo Rivera
- Joseph E. Robach
- James Sanders Jr.
- Susan Serino
- Daniel L. Squadron
- Toby Ann Stavisky
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Relates to the purchase of prescription drugs
In Senate Committee · Insurance · Sponsor Latoya Joyner
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:S2530
Title of bill
An act to amend the insurance law, in relation to the purchase of prescription drugs
Purpose or general idea of bill
To clarify and strengthen provisions in current law to ensure that consumers have the option to access every covered medication from a local network participating pharmacy and are not forced to use a mail order pharmacy.
Read the full memo (1,092 words)
Summary of specific provisions
Section 1 of this bill amends paragraph 28 of subsection (i) of section 3216 of the Insurance Law to provide new definitions and to remove certain requirements that have become impediments to the Legislature's intent in this area.
The new definitions are as follows: "Same reimbursement amount" is defined as the same benchmark index, the same 'maximum allowable cost' and the same 'national drug code' used to reimburse all pharmacies participating in the insurance network regardless of whether a pharmacy is a mail order pharmacy or a non-mail order pharmacy. 'Maximum allowable cost' and 'national drug code' are very specific terms that have meaning in the prescription market. "Mail order pharmacy" is defined as any pharmacy whose primary business is to receive prescriptions by mail, telefax or through electronic submissions and to deliver medications through the US mail or common carriers.
Regarding the removal of provisions in the current law, this amendment removes the requirements that a non-mail order retail pharmacy agree "in advance through a contractual network agreement" to the same "terms and conditions" as those imposed on network mail order pharmacies and other non-retail pharmacies. These provisions are being removed because they have served to impose extra requirements on network community pharmacies as a precondition for providing certain covered medications otherwise available by mail order.
Section 2 of this bill amends paragraph 18 of subsection (I) of section 3221 of the Insurance Law in the same manner and to the same extent as section 1 of this bill amends paragraph 28 of subsection (i) of section 3216 of the Insurance Law.
Section 3 of this bill amends subsection (kk) of section 4303 of the Insurance Law in the same manner and to the same extent as section 1 of this bill amends paragraph 28 of subsection (i) of section 3216 of the Insurance Law and as section 2 of this bill amends paragraph 18 of subsection (I) of section 3221 of the Insurance Law.
Section 4 of this bill provides that this act shall take effect immediately.
Justification
In January 2012, the current provisions of Insurance Law took effect guaranteeing that consumers would always have the choice of obtaining covered prescription drugs from a local network participating pharmacy.
Over the course of the year, however, it became clear that the law was not working as intended. Consumers received letters from pharmacy benefit managers directing them to out-of-state "specialty" pharmacies. Consumers returning to their local participating pharmacy could no longer obtain their prescription drugs there because the claim was blocked. The pharmacy was notified that coverage for that medication was no longer covered in the "retail" pharmacy network. The patient was to be directed to the "specialty" pharmacy.
Contrary to the intent of the law, beneficiaries are forced into mandatory mail order programs based upon the medications that they are prescribed. These medications are being deemed to be "specialty" medications and, thus, cannot be filled at a non-specialty retail pharmacy. Local pharmacies in the network were not considered "specialty" pharmacies and, thus, were excluded from the new "restricted" network. This allowed pharmacy benefit managers to steer prescription volume out of the network retail pharmacies into their wholly owned pharmacy subsidiaries. Defining "mail order pharmacy" is necessary so that its meaning cannot be manipulated by self-promoting pharmacy benefit managers.
Community pharmacy owners took action. They contacted plan sponsors and pharmacy benefit managers asking for contracts that would allow them to continue to dispense covered medications available to them from their wholesalers. The phone calls, letters, and e-mails that followed document that large pharmacy benefit managers were using "terms and conditions" as a legal roadblock against community pharmacies. These included unreasonable and onerous "terms" such as costly accreditations, on-call 24-hour nursing services, and excessive liability insurance demands. Some threatened to exclude community pharmacies from the retail network in order to be enrolled as a mail order pharmacy. For these reasons, it is necessary to remove "terms and conditions" from current law.
The term "in advance through a contractual network agreement" has served as another roadblock to the community pharmacies envisioned in the original law. A close reading of the law allows a local network pharmacy to agree to accept the same reimbursement amount, but nothing in the law requires the pharmacy benefit manager to grant the participating community pharmacy an additional contract to meet the mail order reimbursement price. The present statute must be amended to resolve this contradiction and restore the original legislative intent.
Consumers have had many issues with mail order pharmacies. When medication requires refrigeration, spoilage is an issue for consumers. Because many consumers are employed and cannot control the time that the medication will be delivered, medication that requires refrigeration could be left outside in the sun for an extended period of time melting whatever cold packaging was included to keep the medication refrigerated.
Additionally, many medications have been lost in the mail or stolen. When medication that a person relies on in order to maintain his or her health is lost or stolen, that person's health is placed at risk. This risk is intensified by the fact that the only replacement option is the mail order pharmacy, which means that the replacement medication may not arrive for days. Because many prescriptions cannot be refilled more than one week ahead of time, a person could run out of the medication while he or she waits for a second delivery. While it could be argued that the person could simply wait at home for the medication to be delivered, this argument ignores some practical realities such as employment and the inability to simply take a day off from work to wait for a package to be delivered.
The original intent of the law has been distorted. These proposed amendments are reasonable and fair. With these amendments, the original legislative intent will be restored. Consumers will finally have the ability to use in-network community pharmacies for their prescriptions, regardless of whether the medication is considered to be a "specialty" medication.
Legislative history
2014: S.3995B - Referred to Insurance 2013: S.3995B - Referred to Insurance
Fiscal implications
None
Effective date
This act shall take effect immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.